[VIRTUAL] IMPACT OF NOVEL HYDROGEN SULFIDE-RELEASING KETOPROFEN (ATB-352) ON MOLECULAR PATHWAYS AND MICROBIOME PROFILE IN GASTROINTESTINAL (GI) TRACT WITH POSSIBLE DEVELOPMENT OF GI-SAFE POLYPHARMACY WITH OTHER NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)

hydrogen sulfide-releasing derivative of ketoprofen (ATB-352) - Antibe

omeprazole - Generic mfg.

naproxen - Generic mfg.

otenaproxesul (ATB-346) - Antibe

https://eventpilotadmin.com/web/page.php?page=Session&project=DDW21LITE&id=3522886

Urszula Glowacka; Katarzyna Magierowska; Dagmara Wójcik; Jerzy Hankus; Edyta Korbut; Malgorzata Szetela; Jakub Cieszkowski; Aleksandra Danielak; John L. Wallace; Marcin Magierowski

Mar 15, 2021